Healthcare
Live Price
Offline$387.18
+2.29% today
1Y Change
+3.63%
Window
Jun 25, 2025 โ Jun 24, 2026
Coverage: 250 bars ยท Jun 25, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
HCA Healthcare, Inc. (HCA) is a Healthcare stock with a market cap of $97.13B and listed on NYSE. The stock last traded around $387.18 and up 3.6% across the available one-year price window (Jun 25, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +7.1%, EPS growth of +28.5%, a dividend yield of 0.7%. What stands out right now is revenue +7.1%, EPS +28.5%, free cash flow +36.4% with operating margin 15.7% and ROIC 18.8%. The dividend is present but secondary, with a yield around 0.7%. Valuation is more restrained than many high-expectation growth names at P/E 14.5 and price/sales 1.3. Stock Foundry combines HCA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+7.1% vs +7.6% peer median
Operating Margin
Below sector median
+15.7% vs +19.4% peer median
P/E
Below sector median
14.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 24, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +7.1% and EPS at +28.5%, with operating margin around 15.7%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 0.7%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +0.6% over the next 5 trading days and finished higher after 2 of those reports.
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 24, 2026 | โ | +3.1% | +0.1% | -8.9% |
2026 Jan 27, 2026 | +7.4% | -2.9% | -1.3% | +6.9% |
2025 Oct 24, 2025 | +20.2% | +4.7% | +2.8% | +9.8% |
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
HCA
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
HCA Max Drawdown
-33.72%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for HCA and SPY.

Company Overview
HCA Healthcare, Inc.
New York Stock Exchange
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, the company operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. As of December 31, 2021, it operated 182 hospitals, including 175 general and acute care hospitals, five psychiatric hospitals, and two rehabilitation hospitals; 125 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
Valuation, growth, profitability, and balance sheet signals.
Company announcements and filings-style updates.
Next Step
After the overview, the strongest next step is usually chart context or a tighter compare set.